Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

black woman breast cancer pink ribbon

Experts cite 'urgent need' for changes to USPSTF breast cancer screening recommendations

The USPSTF’s update suggests that women should screen every other year, but the group's own modeling studies have cited the benefits of annual screening.

Scan workflow WVU radiology

Remote radiologists prioritize financial gain when choosing reads: 2 possible fixes

An intense focus on RVU productivity may have unintended negative consequences, experts wrote in the Journal of Operations Management.

framework for regulating healthcare artificial intelligence

US senators introduce legislation to strengthen payment for diagnostic imaging agents

The American College of Radiology, SNMMI and the Michael J. Fox Foundation, among others, voiced support for the FIND Act. 

Thumbnail

Rad Partners touts ‘dramatic’ MRI time reductions; Strategic Radiology adds practice, plus more company news

Also, radiologist joins state medical society representing small groups, and three LucidHealth rads honored as "top docs." 

Thumbnail

How age, gender and medical specialty affect a physician's risk of being sued

New data from the American Medical Association reveal that nearly one-third of physicians in the United States have been sued during their medical career. 

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

Artificial intelligence in healthcare

Industry Watcher’s Digest

Buzzworthy developments of the past few days.